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In 1996, three viral proteins, NB of influenza B virus prior to molecular cloning of the cDNA and the expres-
sion of the ion channel in heterologous systems. Thus,and Vpu and Vpr of human immunodeficiency virus type
1 (HIV-1), were reported in the literature as having an the characteristics of the channel properties could be
anticipated. However, for candidate viral protein ionion channel activity (Ewart et al., 1996; Piller et al., 1996;
Schubert et al., 1996b; Sunstrom et al., 1996). Thus, in- channel activity, prior knowledge of their electrophysio-
logical properties is rarely known.cluding the well-characterized influenza A virus M2 pro-
tein, there are now four viral proteins that are reported When a candidate viral ion channel protein is ex-
to act as ion channels. However, demonstrating that a pressed in tissue culture cells or in oocytes of X. laevis
viral protein has an ion channel activity that is relevant and a new cell surface conductance is recorded, it is
to the life cycle of a virus or in causing viral pathogenesis usually assumed that this current results directly from
is not a simple problem. expression of the viral protein. Although this may be a
Ion channels are generally accepted to be integral correct conclusion, the caveat must be added that ex-
membrane proteins that contain an aqueous accessible pression of several small integral membrane proteins of
proteinaceous core (the channel pore) that can allow a both viral and cellular origin, at least in the oocyte sys-
massive flux of ions (107 –108 ions per second) across a tem, is capable of regulating a channel(s) endogenous
membrane. In contrast, some water-soluble peptides can to the host cell (Attali et al., 1993; Shimbo et al., 1995;
promote the local breakdown of the membrane bilayer Tzounopoulos et al., 1995). Thus, unless a specific
creating a lipidic pore with a surface formed completely blocker of the candidate channel is available, it may be
or partially by polar lipid headgroups. The biophysical difficult to distinguish whether the current observed is
characteristics of these lipidic pores are not as well de- intrinsic to the expressed viral protein. One approach
fined as those of ion channels and are usually dependent toward overcoming this dilemma is to make mutations
on the lipid composition of the membrane (Chernomordik in the presumptive channel pore region, seek changes
et al., 1994). in properties of the channel (e.g., altered ionic selectivity,
Ion channel activity is detected by measuring changes gating, or inactivity), and correlate these observations
in cell surface currents, either of whole cells or of single with the effect of incorporating the same mutations into
macromolecular complexes (single channel recordings). the virus genome.
One of the simpler methods to analyze ion channel pro- To demonstrate that an ion channel activity is a bona
teins is to express the proteins either in tissue culture fide property of the purified channel protein, attempts are
cells or in oocytes of Xenopus laevis. This method re- often made to reconstitute the ion channel in planar lipid
quires that the candidate protein is expressed at the bilayers. Thus, this technique can be used to confirm
surface of cells in order to measure ion channel currents. properties of the ion channel activity measured by other
For the ion channels of many specialized cells the nature means. If there is a concordance among the data, then
of the surface currents had been measured in organs it can be safely concluded that the ion channel activity
is intrinsic to the purified protein. However, in the ab-
sence of supporting data interpretation of results ob-
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cells can induce ion channel activity when introduced transmembrane (TM) residues, and 54 C-terminal intra-
cellular cytoplasmic residues (Holsinger and Lamb, 1991;into planar lipid bilayers (Tosteson et al., 1988, 1989).
Furthermore, great care must be taken to ensure that Lamb et al., 1985; Sugrue and Hay, 1991). Today it is
thought that once a virion has entered the cell by endocy-the protein or peptide preparations are pure, as minor
chemical contaminants (e.g., low concentrations of deter- tosis and it is in the acidic environment of the endosomal
lumen, the virion-associated M2 ion channel permits thegent) can cause membrane perturbations and spurious
conductances between the chambers of the bilayer ap- passage of protons across the virion membrane into the
virion core. The lowered intravirion pH is presumed toparatus. Recordings of membranes modified by peptides
such as cecropins or magainins show a variety of ampli- weaken protein–protein interactions between the matrix
(M1) protein and the ribonucleoprotein (RNP) core (re-tudes over a wide range, noisy baselines, and low ionic
selectivities (Chernomordik et al., 1994; Christiansen et viewed in Helenius, 1992) and considerable evidence
has been accumulated recently indicating that a low pHal., 1988; Duclohier et al., 1989) and such activity is often
believed to be that of a lipidic pore. In contrast, ion chan- step is required to remove M1 protein from the RNPs
(Bui et al., 1996; Zhirnov, 1992). Upon fusion of the virionnel-forming peptides (e.g., alamethicin, nystatin, and
gramicidin) have high selectivity and quantized ampli- envelope with the endosomal membrane, free RNPs are
released which are competent for transport into the nu-tudes over a narrow range (reviewed in Sansom, 1991).
A different approach toward determining that a viral cleus (Bukrinskaya et al., 1982; Martin and Helenius,
1991). In the presence of amantadine influenza virus un-protein can act as a lipidic pore or an ion channel is to
look for membrane permeability changes when the pro- coating is incomplete, the M1 protein is not released
from the RNPs, and the RNPs fail to enter the nucleustein is expressed in bacteria or mammalian cells, for
example, using as an indicator increased uptake from (Bukrinskaya et al., 1982; Martin and Helenius, 1991). As
discussed below a second role of the M2 ion channel inthe growth medium of an intracellularly acting inhibitor
(Guinea and Carrasco, 1994, reviewed in Carrasco, the life cycle of influenza virus is for the M2 protein to
function during its transport through the exocytic pathway1995). However, these measurements are not direct mea-
surements of ion channel activity as it is possible that and to modulate the pH of the Golgi cisternae (reviewed
in Hay, 1992; Lamb et al., 1994).the action of one protein in a membrane may cause pore
formation by another. The notion that the M2 protein has an ion channel
activity stemmed initially from investigation of the modeIn considering whether viral proteins have an ion chan-
nel activity it is useful to envisage a specific role for the of action of the anti-influenza A virus drug amantadine.
The drug inhibits the ‘‘early’’ step of uncoating of influenzaion channel activity in the life cycle of the virus from the
viewpoint of virus replication and/or virus–cell interac- A virus and for some influenza A virus subtypes amanta-
dine also inhibits a step ‘‘late’’ in the replicative cycletions. Ion channels are well-known targets for specific
inhibition by drug action and thus viral ion channel activity (reviewed in Hay, 1992; Lamb et al., 1994). Mutants of
influenza virus resistant to amantadine contain aminoprovides a well-defined target for new antiviral chemo-
therapeutics. In this review we discuss the known biologi- acid changes in the M2 protein transmembrane domain
suggesting an interaction of amantadine with the M2 pro-cal properties in virally infected cells and the electrophysi-
ological properties of the M2 and NB proteins of influenza tein (Hay et al., 1985). Later, it was observed that the
late effect of amantadine on viral replication involved theA and B viruses and Vpu and Vpr proteins of HIV-1.
hemagglutinin (HA). A large body of immunological and
biochemical data indicated that addition of amantadineINFLUENZA A VIRUS M2 PROTEIN:
to cells late in infection caused HA to undergo its confor-BIOLOGICAL ASPECTS
mational change to the low pH-induced form in the trans-
Golgi network (TGN) (Ciampor et al., 1992a,b; GrambasA major strength in the development of the case that
the influenza A virus M2 protein has an ion channel activ- et al., 1992; Grambas and Hay, 1992; Sugrue et al., 1990).
Addition of the Na//H/ ionophore monensin at low con-ity came from understanding the biology of viral replica-
tion and its inhibition by the antiviral drug amantadine centrations (nanomolar) to amantadine-treated infected
cells restored HA to its pH neutral form, without affectingbefore electrophysiological experiments showed that the
M2 protein has an ion channel activity which is inhibited HA transport, functionally overcoming the amantadine
block of the M2 ion channel and suggesting a similarityby amantadine. The influenza A virus M2 integral mem-
brane protein is abundantly expressed in virus-infected in mechanism of monensin and the M2 ion channel
(Grambas et al., 1992; Sugrue et al., 1990). Thus, the M2cells (Lamb and Choppin, 1981; Lamb et al., 1985; Zeb-
edee et al., 1985) but it is only a minor, albeit essential, ion channel activity is thought to function in the TGN and
associated transport vesicles to keep the pH above thecomponent of virions (Zebedee and Lamb, 1988). The
M2 protein is a disulfide-linked homotetramer with each threshold at which the HA conformational change to the
low pH-induced form occurs (Ciampor et al., 1992a;chain consisting of 97 amino acids, and it is thought
that there are 24 N-terminal extracellular residues, 19 Sugrue et al., 1990). Further evidence that the M2 protein
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can alter the pH of intracellular compartments in the influenza B virus NB protein is a type III integral mem-
brane protein (classification of von Heijne, 1988) with anabsence of an influenza virus infection was obtained by
examining the effect of M2 on the biogenesis of HA when 18-residue N-terminal extracellular domain, a 22-residue
transmembrane domain, and a 60-residue cytoplasmicHA and M2 were expressed from cDNAs (Ohuchi et al.,
1994; Sakaguchi et al., 1996; Takeuchi and Lamb, 1994). tail (Shaw et al., 1983; Williams and Lamb, 1986) but M2
and NB do not share amino acid identity. The NB protein
is abundantly expressed at the surface of virus-infectedINFLUENZA A VIRUS M2 PROTEIN:
ELECTROPHYSIOLOGICAL MEASUREMENTS cells (Shaw and Choppin, 1984; Williams and Lamb,
1986) and most importantly for its proposed role in virus
Direct evidence that the M2 protein has ion channel uncoating, NB is incorporated at low levels into virions
activity was provided by expressing the M2 protein in (Betakova et al., 1996; Brassard et al., 1996). As described
either oocytes of X. laevis (Holsinger et al., 1994, 1995;
above, the elucidation of the role of the influenza A virus
Pinto et al., 1992; Sakaguchi et al., 1997; Shimbo et al.,
M2 protein stemmed from studies on understanding the1996; Tu et al., 1996; Wang et al., 1993, 1995a) or in
mechanism of action of the antiviral drug amantadine.
mammalian cells (Chizhmakov et al., 1996; Wang et al.,
However, influenza B virus replication is not inhibited by
1994a) and measuring cell surface currents. The M2 ion amantadine at micromolar concentrations (Davies et al.,
channel activity is specifically blocked by the anti-influ-
1964) and there is no other known specific inhibitor of
enza virus drug amantadine and is activated at the low-
influenza B virus replication. At millimolar concentrations
ered pH found intralumenally in endosomes and the
amantadine inhibits the uncoating of influenza B virus
TGN (Chizhmakov et al., 1996; Pinto et al., 1992; Shimbo
and many other enveloped viruses that enter cells
et al., 1996; Wang et al., 1995a). In addition, introduction
through the endocytic pathway and need lowered pH to
of purified M2 protein or the TM domain peptide into trigger fusion of the viral envelope with the endosomal
planar lipid bilayers resulted in an amantadine-sensitive
membrane. This is because amantadine can act as a
ion channel activity that was activated by low pH (Duff
lysosomaltropic agent (similar to NH4Cl or chloroquine)and Ashley, 1992; Schroeder et al., 1994; Tosteson et
and raise the lumenal pH of intracellular compartments
al., 1994).
(reviewed in Mellman et al., 1986).
Thus, all the accumulated data indicate that the influ-
enza virus M2 is an ion channel protein and that it is a
INFLUENZA B VIRUS NB PROTEIN:minimalistic or primative ion channel by comparison to
ELECTROPHYSIOLOGICAL MEASUREMENTSthe multi-membrane-spanning domain structure of many
eukaryotic ion channels.
Expression of NB in oocytes of X. laevis acts as an
activator of an endogenous chloride conductance
INFLUENZA B VIRUS NB PROTEIN:
(Shimbo et al., 1995), and a similar current can be evoked
BIOLOGICAL ASPECTS
from oocytes that express a variety of cellular and viral
small integral membrane proteins (Attali et al., 1993;The influenza B virus replicative cycle is very similar
to that of influenza A virus and in vitro experiments sug- Shimbo et al., 1995; Tzounopoulos et al., 1995). Thus, the
oocyte system which has proven extremely useful forgest that a low pH step is required to release the matrix
protein from the RNPs (Zhirnov, 1990, 1992). Thus, it expression and measurement of many heterologous ion
channels does not prove useful for examination of an ionseems reasonable to believe that influenza B virions con-
tain an ion channel to permit ions to enter the virion channel activity intrinsic to NB.
Ion channel activity in artificial lipid bilayers has beenand weaken protein–protein interactions. Neither is the
influenza B virus HA cleaved in the TGN nor is the pH reported after addition of purified NB protein synthesized
in Escherichia coli (Sunstrom et al., 1996). Lipid bilayersrequired for HA to induce fusion (pH 5.4) (Brassard and
Lamb, unpublished observation) above that of the pH of have been used as a model system to study the proper-
ties of many ion channels, both ligand- and voltage-the Golgi lumen. Therefore, there is not a requirement a
priori for an ion channel to equilibrate the pH of the gated. However, as mentioned above, the starting point
for the use of this model system is usually the knownlumen of the TGN with the cytoplasm to keep HA in its
pH neutral form. Unlike RNA segment 7 of influenza A properties of the channel, determined from recordings
made in cells. There are two reasons for this: first, pro-virus which encodes the matrix (M1) and M2 ion channel
proteins (Lamb et al., 1981), influenza B virus RNA seg- teins and peptides containing hydrophobic domains
which are believed not to have ion channel activity inment 7 does not encode an integral membrane protein
equivalent of the M2 protein (Briedis et al., 1982). How- cells are able to yield channel recordings in lipid bilayers
(Lear et al., 1988; Tosteson et al., 1988, 1989); second, ifever, influenza B virus RNA segment 6 encodes a small
integral membrane protein, NB (100 amino acids) (Shaw a eukaryotic integral membrane proteins is expressed in
E. coli it frequently leads to folding and oligomerizationet al., 1982, 1983), and thus it is tempting to speculate
that NB has an ion channel activity. As with M2 protein, problems (reviewed in Doms et al., 1993) and it cannot
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be determined if the TM domain is inserted into bilayers with an N-terminal 24-residue hydrophobic membrane-
spanning domain and a C-terminal cytoplasmic tailin its natural manner. Antibody to the NB C-terminus
inhibited channel activity suggesting that the activity was (Maldarelli et al., 1993) which forms homooligomers of
an undetermined number of subunits (Maldarelli et al.,due to NB and not a contaminant (Sunstrom et al., 1996).
Nonetheless, the data must be treated cautiously be- 1993). The Vpu cytoplasmic tail is specifically phosphory-
lated on serine residues 52 and 56 (Friborg et al., 1995;cause there is no a priori information about the NB chan-
nel and it is possible that the ion channel activity re- Schubert et al., 1994; Schubert and Strebel, 1994). As
with M2 and NB of influenza A and B viruses, Vpu is acorded in the bilayer experiments was not representative
of the function of the NB protein in either the virion or type III integral membrane protein. However, unlike M2
and NB proteins which are abundantly expressed at theinfected cells. One of the strengths of this model system
is the ability to detect currents that result from a single cell surface (Lamb et al., 1985; Williams and Lamb, 1986),
Vpu is largely expressed intracellularly (Klimkait et al.,macromolecular complex, but this strength can also
cause difficulty in the interpretation of results, as the 1990; Schubert et al., 1996a) and in an HIV-1 infection
Vpu is not detected at the cell surface, a finding whichrecorded activity cannot be attributed definitively to the
majority protein without substantiating evidence such as may account for its seeming absence from virions
(Strebel et al., 1989). Nonetheless, when Vpu is overex-that provided by application of a specific inhibitor. The
bilayer experiments did demonstrate that 2–3 mM aman- pressed, using expression vectors, some Vpu is ex-
pressed at the cell surface (Maldarelli and Strebel, un-tadine inhibited the measured permeability (Sunstrom et
al., 1996). However, such high concentrations of amanta- published observations cited in Schubert et al., 1996).
Vpu is designated an HIV-1 accessory protein becausedine have also been shown to inhibit the nicotonic acetyl-
choline receptor, the NMDA (N-methyl-D-aspartate) re- its gene can be deleted from HIV-1 without completely
abrogating virus replication in vitro (Cohen et al., 1988;ceptor channel, and ATP-regulated K-currents in HIT-T15
cells (Albuquerque et al., 1978; Ashcroft et al., 1991; Bre- Klimkait et al., 1990; Strebel et al., 1988, 1989). However,
expression of Vpu has been shown to enhance virussink et al., 1995; Warnick et al., 1982).
In separate experiments Ewart and co-workers (1996) particle release from a wide variety of cell types (Schu-
bert et al., 1995; Strebel et al., 1988; Terwilliger et al.,investigated whether NB permitted H/ to permeate, using
a NADH-dependent quinacrine fluorescence-quenching 1989). It was found both in A3.01 cells and HeLa cells
transiently expressing CD4 that there was a two- to four-assay and membrane vesicles prepared from E. coli ex-
pressing NB protein. The vesicles showed a reduced fold increase in particle secretion in cultures infected
with wt HIV-1 compared to cultures infected with a vpu-quinacrine fluorescence-quenching activity compared to
control E. coli, suggesting that the vesicles were unable deficient HIV-1 (Schubert et al., 1995, 1996a; Strebel et al.,
1989). With vpu-deficient HIV-1, a significant proportion ofto maintain a high H/in/H
/
out ratio due to a proton flux
through an NB channel. However, such measurements the virions remains associated with the cell surface and
there is the formation of intracytoplasmic particles, oftenare indirect and could reflect flux through a preexisting
or NB-induced E. coli-specific channel. It is unfortunate of aberrant morphology, contained within membranous
vacuoles (Klimkait et al., 1990). Interestingly, vortexing ofthat the M2 protein was not tested in parallel, as it is know
to have a proton flux and can be inhibited by micromolar vpu-deficient HIV-1-infected cells caused a large propor-
tion of the cell-associated particles to be released, sug-concentrations of amantadine. Nonetheless, there is still
a risk of correlating directly an effect with a causative gesting that they are held to cells by a loose association
(Klimkait et al., 1990). It was also observed that vpu-mechanism because we note that when influenza virus
M2 protein was expressed in yeast, the amantadine-sen- deficient HIV-1 caused a considerably greater cytopathic
effect than wt HIV-1, perhaps due to the intracellularsitive M2-specific proton flux caused acidification of the
extracellular medium possibly due to a disruption of the accumulation of possibly toxic HIV-1 proteins (Klimkait
et al., 1990; Schubert et al., 1995; Yao et al., 1992).plasma membrane H/-ATPase-generated electrochemi-
cal gradient (Kurtz et al., 1995). A second function of Vpu is to induce the specific
degradation of CD4, one of the two HIV-1 coreceptorOur present understanding of the replication of influ-
enza B virus leads us to expect that the NB protein func- molecules, during transport of CD4 through the exocytic
pathway (Lenberg and Landau, 1993; Vincent et al., 1993;tions as an ion channel. However, a great deal of work
needs to be done to extrapolate the observed bilayer Willey et al., 1992a,b). A significant proportion of the HIV-
1 envelope glycoprotein precursor gp160 forms a stabledata for NB ion channel activity to an activity of the NB
protein in virus-infected cells or virions. complex with CD4 and this complex is trapped in the
endoplasmic reticulum (ER) (Bour et al., 1991; Buonocore
and Rose, 1990; Crise et al., 1990; Jabbar and Nayak,HIV-1 Vpu: BIOLOGICAL ASPECTS
1990). Release of gp160 from an intracellular trap is pre-
dicted to increase the infectivity of HIV-1 virions. In theThe HIV-1 Vpu protein is an 81-residue integral mem-
brane protein (Cohen et al., 1988; Strebel et al., 1988), presence of Vpu, the stability of CD4 is reduced 30- to
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40-fold (Willey et al., 1992b). It is thought likely that degra- is not thought that Vpx is the functional equivalent of
dation of CD4 in the ER utilizes the same pathway as Vpu, as the two proteins are structurally dissimilar. In
used by cells to degrade proteins that fail to fold or an analysis of chimeric retroviruses bearing the gag-pol
oligomerize correctly. regions of retroviruses that naturally lack vpu, it was
The two activities of Vpu, induction of CD4 degradation found that expression of HIV-1 Vpu augmented the re-
in the ER and enhancement of virus release, involve the lease of these viruses, suggesting that the function of
two distinct structural domains of the protein, the cyto- Vpu is not restricted to HIV-1 (Gottlinger et al., 1993).
plasmic tail and the TM domain, respectively, and the two Recent experiments have shown that Env of HIV-2 has
activities occur in different intracellular compartments the ability to regulate positively HIV-2 particle release
(Schubert et al., 1996a; Schubert and Strebel, 1994). For (Bour et al., 1996; Bour and Strebel, 1996; Ritter et al.,
Vpu-mediated degradation of CD4 the Vpu cytoplasmic 1996) and that if HIV-2 Env is expressed in trans with a
tail must be specifically phosphorylated on serine resi- HIV-1 vpu-deficient mutant, HIV-2 Env restored the en-
dues 52 and 56 (Schubert et al., 1996a; Schubert and hancement of virus released (Bour and Strebel, 1996).
Strebel, 1994), and the Vpu cytoplasmic tail interacts Thus, it appears that Env of HIV-2 can functionally re-
physically with the cytoplasmic tail of CD4 (Bour et al., place Vpu to enhance the rate of particle release. HIV-2
1995). This interaction releases gp160 from the gp160/ may not need the Vpu function of causing release of Env
CD4 complex, allowing transport of gp160 to the cell from CD4 in the ER because the affinity of HIV-2 gp140
surface and initiating CD4 degradation in the ER. The for CD4 is 10- to 200-fold lower than that of HIV-1 gp160
conclusion that the Vpu TM domain was involved in viral (Bahraoni et al., 1992; Ivey-Hoyle et al., 1991; Mulligan
release function was determined from experiments using et al., 1992).
a mutant, VpuRD , which contained a scrambled TM do- It has been found that two regions of HIV-1 gp41 cause
main sequence that was predicted to maintain an a- pore formation in planar membranes or E. coli. The do-
helical structure. VpuRD was found to be incorporated mains of gp41 are the TM domain and residues 828 to
normally into membranes, was able to form homooligo- 848 located in the C-terminus of the cytoplasmic tail, a
mers, and was expressed stably and localized in a peri- region predicted to form an amphipathic helix (Arroyo et
nuclear distribution like wt Vpu. Whereas VpuRD was ca- al., 1995; Chernomordik et al., 1994). It has been sug-
pable of binding to CD4 and inducing CD4 degradation, gested that the C-terminal region of HIV-1 gp41 may inter-
incorporation of the VpuRD mutation into HIV-1 yielded a act with the infected T cell membrane to create a pore
phenotype like that of vpu-deficient HIV-1 in which virions
which in turn increases membrane permeability, leading
were poorly released from infected cells (Schubert et al.,
to sodium and calcium flux, osmotic swelling, and T-cell
1996a). Vpu-mediated enhancement of virus release was
necrosis (Chernomordik et al., 1994). The TM domain
partially dependent on phosphorylation of the Vpu cyto-
pore-forming capability could also be involved in HIV-plasmic tail (a Vpu phosphorylation deficient HIV-1
induced cytopathology (Arroyo et al., 1995) or it could beyielded a 50–100% increase in particle release over vpu-
involved in forming a fusion pore during gp41-mediateddeficient HIV-1) (Schubert et al., 1996a; Schubert and
virus–cell fusion. It is currently unclear if the HIV-1 gp41Strebel, 1994), suggesting that phosphorylation of the
pore-forming ability is related to the ability of HIV-2 gp140Vpu cytoplasmic tail can modify the function of the TM
to functionally replace Vpu.domain. It is interesting to note that 1H NMR and CD
Based on the overall similarity of structure of Vpu tospectroscopy studies indicate that the Vpu cytoplasmic
the influenza A virus M2 protein and the need to explaindomain consists of two amphipathic a-helices and these
the mechanism of action of the two functions of Vpu,two a-helices are joined by a flexible highly acidic inter-
Willey and co-workers (1992a) rationalized that Vpu mightconnecting hinge region containing both phosphoaccep-
have an ion channel function. Once the data using VpuRDtor sites (Federau et al., 1996; Wray et al., 1995). Thus,
were obtained it was proposed that the Vpu TM domainit is possible that the phosphorylated region of Vpu might
forms an ion conductive membrane pore (Schubert etact as a hinge domain and undergo conformational
al., 1996a). It was envisaged that Vpu could be directlychanges that regulate biological activity. Phosphorylation
involved in virus release at the cell surface, although littleis thus likely to regulate both activities of the Vpu pro-
Vpu is expressed at the cell surface. An alternative ideateins, including TM domain-mediated enhancement of
also proposed was that the postulated Vpu ion channelvirus release.
activity would function to prevent intracellular budding ofAlthough HIV-1 encodes Vpu, none of the other primate
virus (Schubert et al., 1996a). Given that HIV-2 Env canor nonprimate lentiviruses encode a Vpu-like protein, ex-
functionally replace Vpu to enhance the rate of HIV-1cept for the chimpanzee simian immunodeficiency virus
particle release, the inference is that HIV-2 Env would(Huet et al., 1990). The main difference in genome organi-
also have an ion channel activity, presumably involvingzation between HIV-1 and HIV-2 is the presence of vpu
the TM and/or lengthy cytoplasmic tail of gp41 (Bour etin HIV-1, which is absent from HIV-2, and the presence
of vpx in HIV-2, which is absent from HIV-1. However, it al., 1996; Ritter et al., 1996).
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HIV-1 Vpu: ELECTROPHYSIOLOGICAL tion of the cytoplasmic tail would cause a gain of function
of an ion channel activity over phosphorylated wt Vpu. AnMEASUREMENTS
inherent difficulty with Vpu is that it lacks an ectodomain
To test if Vpu had an ion channel activity it was ex- recognizable by an antibody, thus making it difficult to
pressed in E. coli as a glutathione S-transferase (GST) show if Vpu is expressed at the surface of oocytes; sur-
fusion protein, released by thrombin cleavage, and puri- face expression is a prerequisite for whole-cell channel
fied by HPLC anion-exchange chromatography (Ewart et recordings. Indeed, as discussed above, very little wt
al., 1996). After applying Vpu to bilayers, variable currents Vpu is thought to be transported to the plasma membrane
of over a 20-fold range of amplitude were recorded and of mammalian cells. To attempt to show that the Vpu TM
they showed permeability to Na/, K/, Cl0, and phosphate domain is the ion conductive pore of a channel, Schubert
ions. The combination of a wide range of amplitude and and co-workers (1996b) constructed a chimeric mole-
permeability is consistent with a generalized membrane cule, VpuR26 , in which the Vpu TM domain sequence was
perturbation (see Lear et al., 1988). As discussed above randomized and the cytoplasmic tail was derived from
for the studies with NB, the lipid bilayer system serves Vpu2/6 . The VpuR26 randomized hydrophobic domain still
well as a model for study of ion channels that are already acts as a transmembrane domain (Schubert et al., 1996a)
well-characterized, but in attempting to characterize yet when VpuR26 was expressed in oocytes even at high
channels de novo there is the risk that the bilayer system levels, no surface current was detected. When VpuR26
may report ion channel activity of proteins that are not was incorporated into the HIV-1 genome it yielded a phe-
ion channels. This is of particular concern when the fold- notype that is indistinguishable from vpu-deficient HIV-
ing and oligomerization state of a protein synthesized 1. Thus, there is an interesting correlation of findings in
and purified from bacteria have not been evaluated. that the VpuR26 mutation has an effect on the ion channel
As a separate line of investigation it was found that activity induced by expression of Vpu and also on the
an E. coli proline auxotroph could be made to grow under biology of HIV-1 replication.
conditions that required the dissipation of a Na/ gradient Schubert and co-workers (1996b) extended their stud-
of adjacent E. coli cells expressing the Vpu protein and ies by examining the ion channel-forming ability of the
the consequent leakage of proline from these cells Vpu TM domain peptide. When studied under similar
(Ewart et al., 1996). However, this result does not indicate conditions to those used by Ewart et al. (1996) for the
definitively that the Vpu protein formed a Na/ channel in Vpu protein, bilayers exposed to the Vpu TM peptide also
the adjacent cells, as the assay would also yield a posi- showed a range of currents, but in this case the range
tive result if the Vpu protein acted as the auxiliary subunit of amplitude was less, 3:1, and increased in clearly iden-
of a cellular protein, the same difficulty that has plagued tifiable quantized steps; the ion selectivity was also cat-
some expression studies in oocytes (Attali et al., 1993; ionic for the peptide. Unlike the whole-cell currents of
Shimbo et al., 1995; Tzounopoulos et al., 1995). oocytes, bilayers exposed to Vpu peptide did not show
Schubert and co-workers (1996b) expressed the Vpu activation under similar conditions by voltage. The heter-
cytoplasmic tail phosphorylation-deficient mutant Vpu2/6 ogeneity of the size of the conductances presumably
in oocytes of X. laevis and using a two-electrode voltage arises from the nonordered self-assembly of the TM do-
clamp apparatus observed small whole-cell inward cur- main peptides. A peptide (Vpurd) composed of a random-
rents in response to hyperpolarizing membrane voltages ized sequence derived from the Vpu TM domain (and the
(600 nA at 130 mV). The time course of the current was same sequence as found in the TM domain of VpuR26) did
characterized by slow activation by large negative mem- not form ion channels but exhibited erratic fluctuations in
brane voltages, not usually encountered in mammalian membrane currents with variable amplitudes reflecting
cells. Examination of the ion selectivity of the Vpu-in- transient disruptions of the membrane.
duced conductance indicated permeability to monova- Taken together, the data from Ewart and co-workers
lent cations without discriminating Na/ over K/ and the (1996) and Schubert and co-workers (1996b) are sugges-
conductance was pH independent. Vpu2/6 was thought tive that Vpu has a channel activity. The correlation of
not to activate a chloride channel endogenous to oocytes the lack of channel activity of both VpuR26 in oocytes and
that can be activated by other small cellular and viral the peptide Vpurd in bilayers with the biological observa-
membrane proteins (Attali et al., 1993; Shimbo et al., tion of the lack of enhancement of virus release with
1995; Tzounopoulos et al., 1995) based on inhibitor stud- HIV-1 expressing VpuR26 is important. Because electrical
ies (Schubert et al., 1996b); however, in the absence of recordings from oocytes and planar bilayers can lead to
a specific Vpu channel activity blocker, it cannot be ruled ambiguities and artifacts, to show without any doubt that
out that Vpu does not activate an endogenous cation Vpu has an ion channel activity relevant to the HIV life
channel. Unfortunately, wt Vpu did not accumulate in cycle it will be necessary to make electrophysiological
oocytes and thus only very low or background level mem- recordings from mammalian cells, make mutants in the
brane currents were recorded from oocytes expressing Vpu TM domain that alter ionic selectivities to show that
the Vpu TM domain conducts an ionic flux, reconstitutewt Vpu, but it seems unlikely that the lack of phosphoryla-
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the ion channel activity of properly folded and oligo- distinct mechanisms by which HIV-1 preintegration com-
plexes enter the nucleus: an importin-independent path-merized Vpu purified from eukaryotic cells and identify
an inhibitor that blocks channel activity so that the speci- way mediated by Vpr (Vpr lacks a conventional nuclear
localization signal) (Gallay et al., 1996) and an importin-ficity of channel activity can be readily identified, and
also to obtain inhibitor-resistant mutants that map to vpu. dependent pathway mediated in part by the MA protein
(Bukrinsky et al., 1993; Gallay et al., 1995; von SchwedlerIt is also going to require considerable effort to determine
how the ion channel activity observed in vitro relates et al., 1994).
T lymphocytes infected with HIV-1 that contain an in-to and/or causes the known biological action of Vpu in
mediating HIV release. This is because the channel activ- tact vpr gene do not become chronically infected but
ultimately die (He et al., 1995; Mustafa and Robinson,ity requires a large negative membrane voltage to be
activated, not usually found in cells, and, when induced, 1993; Planelles et al., 1995; Rogel et al., 1995), apparently
because expression of Vpr causes cells to accumulatepermits the flow of a large range of ions.
in the G2 phase of the cell cycle (Bartz et al., 1996; Jowett
et al., 1995; Re et al., 1995; Rogel et al., 1995). This is aHIV-1 Vpr: BIOLOGICAL ASPECTS
conserved function of human and primate lentiviruses
(Planelles et al., 1996). Some tumor cell lines differentiateThe HIV-1 Vpr protein is a 96-residue basic protein
containing no uncharged regions longer than 8 residues; as a result of the block to cell proliferation (Levy et al.,
1993). Vpr arrests the cell cycle in G2 by preventing thethus, it lacks a traditional membrane-spanning domain.
Vpr is found as a component of the virion (Cohen et al., activation of the p34cdc2/cyclin B complex. It is thought
that Vpr must act upstream of p34cdc2 activation by de-1990; Wang et al., 1994b). Vpr is another HIV-1 auxiliary
protein, which is not essential for replication in tissue phosphorylation as Vpr expression causes p34cdc2 to re-
main in the phosphorylated, inactive state (Di Marzio etculture but has two confirmed properties. (1) Vpr plays
a role in permitting entry of the viral core into the nucleus al., 1995; He et al., 1995; Jowett et al., 1995; Re et al.,
1995). A low level of activation of transcription driven byof nondividing cells and (2) Vpr prevents the establish-
ment in vitro of chronically infected HIV-1 producer cell the viral LTR has been observed to be mediated by Vpr
(Levy et al., 1993) but this may be a result of cell-cyclelines by causing infected cells to arrest in the G2/M
phase of the cell cycle. As properties of Vpr have been arrest in G2 (Emerman, 1996). Biochemical and genetic
experiments to seek proteins that interact with Vpr haveextensively reviewed very recently (Emerman, 1996), only
a brief synopsis will be provided here. yielded the transcription factor Sp 1 (Wang et al., 1995b),
a 41-kDa cytosolic protein that also coimmunoprecipi-Retroviruses depend on cell division for their replica-
tion because breakdown of the nuclear envelope at mito- tates with the glucocorticoid receptor (Refaeli et al., 1995)
and uracil DNA–glycosylase (Bouhamdan et al., 1996).sis allows the viral preintegration complex to interact
with the host cell chromosomes. In contrast, HIV-1 can However, it is not understood how these proteins can
be related to the process by which Vpr prevents cellsinfect nondividing cells, a factor essential for infection
of terminally differentiated macrophages. Vpr plays a from passing into mitosis.
role in the process by linking the preintegration complex
with the cell nuclear import pathway (Heinzinger et al., HIV-1 Vpr: ELECTROPHYSIOLOGICAL
1994). A minor phosphorylated form of the viral matrix MEASUREMENTS
(MA) protein also participates in this process and in this
regard the functions of MA and Vpr are redundant. In As discussed above, in mammalian cells Vpr is a solu-
ble protein that is transported into the nucleus and novirus-infected cells Vpr accumulates largely in the nu-
cleus (Lu et al., 1993; Mahalingam et al., 1995). A crude biochemical evidence has been obtained to indicate that
Vpr is an integral membrane protein. However, when Vprfractionation of HIV-1-infected cells into nuclear, cyto-
solic, and membrane fractions indicated that 20% of Vpr was expressed as a GST fusion protein in E. coli, purified
by affinity chromatography and thrombin cleavage andwas associated with membranes but when Vpr was ex-
pressed from a vaccinia virus vector, the membrane- tested in planar bilayers, an ion channel activity was
detected which showed a variety of amplitudes and lowassociated Vpr was only 8% of total (Lu et al., 1993).
Established biochemical experiments to test for a pe- ionic selectivity (Piller et al., 1996). The Vpr ion channel
activity was inhibited by antibody to Vpr, suggesting thatripheral or integral association with membranes versus
a fractionation cross-contamination were not performed the activity observed was due to Vpr protein and not a
contaminant (Piller et al., 1996). Although this suggestsand thus the significance of the Vpr found in the mem-
brane fraction cannot be evaluated. Vpr is incorporated that the observed currents were the result of the pres-
ence of the Vpr protein, it is possible that they resultedinto virions through an interaction dependent on a do-
main (p6) located at the C-terminus of the Gag precursor from generalized membrane perturbation that is able to
be modulated by antibodies. As discussed above, in theprotein (Kondo et al., 1995; Lavallee et al., 1994; Lu et
al., 1995; Paxton et al., 1993). There appear to be two absence of other supporting data, planar bilayer data
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reviewers of the manuscript. Nonetheless, the opinions expressed areindicating ion channel activity and its relationship to a
our own. We are indebted to Drs. Schubert, Strebel, and Montal for aproperty of a protein in a virally infected cell must be
preprint of their manuscript and to Dr. Josh Zimmerberg, National Insti-
treated very cautiously. tutes of Health, for insightful discussions. We apologize to authors who
may feel sleighted because their work was not cited but the length
restriction of this review necessitated a curtailment of referencing.CONCLUSIONS
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